SEC Form 4 · accession 0001645627-17-000019
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 22, 2017
Accepted (ET)
Mar 23, 2017 · 12:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0628 | A | 19,824,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.062 | A | 19,825,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0595 | A | 19,826,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0595 | A | 19,827,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0595 | A | 19,828,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0595 | A | 19,829,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0595 | A | 19,830,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0595 | A | 19,831,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0594 | A | 19,832,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.0595 | A | 19,833,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.055 | A | 19,834,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.055 | A | 19,835,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.055 | A | 19,836,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.055 | A | 19,837,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.055 | A | 19,838,649 | D | |
| Common Stock | Mar 22, 2017 | P | 5,000 | $0.0539 | A | 19,843,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.056 | A | 19,844,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.06 | A | 19,845,649 | D | |
| Common Stock | Mar 22, 2017 | P | 1,000 | $0.059 | A | 19,846,649 | D |
Table II — derivative securities
No Table II lines on this filing.